Literature DB >> 7207506

Respiratory function in the muscular dystrophies.

Y Rideau, L W Jankowski, J Grellet.   

Abstract

The purpose of this investigation was to compare the respiratory function of patients with different clinical types of muscular dystrophy (MD). A total of 190 patients representing facioscapulohumeral MD (n = 20), limb-girdle MD (n = 50), Becker MD (n = 20), Duchenne MD (n = 90), and the "intermediate" type of MD (n = 10) were studied using simple spirometric respiratory function tests. The respiratory modifications observed in the 3 adult forms indicate that pulmonary function was almost normal. Respiratory function in Duchenne muscular dystrophy (DMD) was always characterized by a restrictive syndrome which severely impaired pulmonary function. The vital capacity (VC) underwent ascending, plateau, and descending phases during the course of the disease. The VC at the plateau stage may be used as an estimate of life span. The most interesting finding was the high degree of variability in the restrictive syndrome associated with DMD. In the DMD group 30% presented a severe restrictive respiratory syndrome associated with a life span of less than 20 years (Type 1), 40% had a serious restrictive syndrome and variable mortality (Type 2), and the remaining 30% had a moderate restrictive respiratory syndrome (Type 3).

Entities:  

Mesh:

Year:  1981        PMID: 7207506     DOI: 10.1002/mus.880040213

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  21 in total

1.  Respiratory muscle training in Duchenne muscular dystrophy.

Authors:  E Rodillo; C M Noble-Jamieson; V Aber; J Z Heckmatt; F Muntoni; V Dubowitz
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

2.  The natural history of cardiac and pulmonary function decline in patients with duchenne muscular dystrophy.

Authors:  Rolando Roberto; Anto Fritz; Yolanda Hagar; Braden Boice; Andrew Skalsky; Hosun Hwang; Laurel Beckett; Craig McDonald; Munish Gupta
Journal:  Spine (Phila Pa 1976)       Date:  2011-07-01       Impact factor: 3.468

3.  Short-term effect of volume recruitment-derecruitment manoeuvre on chest-wall motion in Duchenne muscular dystrophy.

Authors:  Henri Meric; Line Falaize; Didier Pradon; Matthieu Lacombe; Michel Petitjean; David Orlikowski; Hélène Prigent; Frédéric Lofaso
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

4.  Current treatment and management of dystrophinopathies.

Authors:  Nathalie Goemans; Gunnar Buyse
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

Review 5.  The paradox of muscle hypertrophy in muscular dystrophy.

Authors:  Joe N Kornegay; Martin K Childers; Daniel J Bogan; Janet R Bogan; Peter Nghiem; Jiahui Wang; Zheng Fan; James F Howard; Scott J Schatzberg; Jennifer L Dow; Robert W Grange; Martin A Styner; Eric P Hoffman; Kathryn R Wagner
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-02       Impact factor: 1.784

6.  Long term non-invasive ventilation in the community for patients with musculoskeletal disorders: 46 year experience and review.

Authors:  A Baydur; E Layne; H Aral; N Krishnareddy; R Topacio; G Frederick; W Bodden
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 7.  Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Benjamin A Alman; Susan D Apkon; Angela Blackwell; Laura E Case; Linda Cripe; Stasia Hadjiyannakis; Aaron K Olson; Daniel W Sheehan; Julie Bolen; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

8.  Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.

Authors:  Michelle Wehling-Henricks; Maria C Jordan; Tomomi Gotoh; Wayne W Grody; Kenneth P Roos; James G Tidball
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

9.  Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

Authors:  Justin C DeVanna; Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Eleanor C Hawkins
Journal:  Neuromuscul Disord       Date:  2013-10-24       Impact factor: 4.296

Review 10.  Muscular dystrophy, incurability, eugenics.

Authors:  Y Rideau; F Rideau
Journal:  Acta Myol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.